Risk Factors and Prognosis of Epilepsy Following Brain Abscess: A Nationwide Population-Based Cohort Study.
Journal
Neurology
ISSN: 1526-632X
Titre abrégé: Neurology
Pays: United States
ID NLM: 0401060
Informations de publication
Date de publication:
11 04 2023
11 04 2023
Historique:
received:
14
09
2022
accepted:
13
12
2022
medline:
12
4
2023
pubmed:
23
2
2023
entrez:
22
2
2023
Statut:
ppublish
Résumé
Epilepsy in patients with brain abscess is frequent, but risk factors and prognosis remain undetermined. This study examined risk factors of epilepsy among survivors of brain abscess and associated prognosis. Nationwide, population-based healthcare registries were used to compute cumulative incidences and cause-specific adjusted hazard rate ratios (adj. HRRs) with 95% CIs for epilepsy among 30-day survivors of brain abscess from 1982 through 2016. Data were enriched with clinical details by medical record review of patients hospitalized from 2007 through 2016. Adjusted mortality rate ratios (adj. MRRs) were examined using epilepsy as a time-dependent variable. The study included 1,179 30-day survivors of brain abscess among whom 323 (27%) developed new-onset epilepsy after a median of 0.76 years (interquartile range [IQR] 0.24-2.41). At admission for brain abscess, the median age was 46 years (IQR 32-59) in patients with epilepsy compared with 52 years (IQR 33-64) in those without epilepsy. The proportion of female individuals was similar in patients with and without epilepsy (37%). Adj. HRRs for epilepsy were 2.44 (95% CI 1.89-3.15) for aspiration or excision of brain abscess, 2.37 (1.56-3.60) for alcohol abuse, 1.75 (1.27-2.40) for previous neurosurgery or head trauma, 1.62 (1.17-2.25) for stroke, and 1.55 (1.04-2.32) for age group 20-39 years. Cumulative incidences were increased in patients with alcohol abuse (52% vs 31%), aspiration or excision of brain abscess (41% vs 20%), previous neurosurgery or head trauma (41% vs 31%), and stroke (46% vs 31%). Analysis using clinical details from medical record review of patients from 2007 through 2016 demonstrated adj. HRRs of 3.70 (2.24-6.13) for seizures at admission for brain abscess and 1.80 (1.04-3.11) for frontal lobe abscess. By contrast, adj. HRR was 0.42 (0.21-0.86) for occipital lobe abscess. Using the entire registry-based cohort, patients with epilepsy had an adj. MRR of 1.26 (1.01-1.57). Important risk factors of epilepsy were seizures during admission for brain abscess, neurosurgery, alcoholism, frontal lobe abscess, and stroke. Epilepsy was associated with an increased mortality. Antiepileptic treatment may be guided by individual risk profiles, and a specialized follow-up is highlighted by an increased mortality in survivors with epilepsy.
Sections du résumé
BACKGROUND AND OBJECTIVES
Epilepsy in patients with brain abscess is frequent, but risk factors and prognosis remain undetermined. This study examined risk factors of epilepsy among survivors of brain abscess and associated prognosis.
METHODS
Nationwide, population-based healthcare registries were used to compute cumulative incidences and cause-specific adjusted hazard rate ratios (adj. HRRs) with 95% CIs for epilepsy among 30-day survivors of brain abscess from 1982 through 2016. Data were enriched with clinical details by medical record review of patients hospitalized from 2007 through 2016. Adjusted mortality rate ratios (adj. MRRs) were examined using epilepsy as a time-dependent variable.
RESULTS
The study included 1,179 30-day survivors of brain abscess among whom 323 (27%) developed new-onset epilepsy after a median of 0.76 years (interquartile range [IQR] 0.24-2.41). At admission for brain abscess, the median age was 46 years (IQR 32-59) in patients with epilepsy compared with 52 years (IQR 33-64) in those without epilepsy. The proportion of female individuals was similar in patients with and without epilepsy (37%). Adj. HRRs for epilepsy were 2.44 (95% CI 1.89-3.15) for aspiration or excision of brain abscess, 2.37 (1.56-3.60) for alcohol abuse, 1.75 (1.27-2.40) for previous neurosurgery or head trauma, 1.62 (1.17-2.25) for stroke, and 1.55 (1.04-2.32) for age group 20-39 years. Cumulative incidences were increased in patients with alcohol abuse (52% vs 31%), aspiration or excision of brain abscess (41% vs 20%), previous neurosurgery or head trauma (41% vs 31%), and stroke (46% vs 31%). Analysis using clinical details from medical record review of patients from 2007 through 2016 demonstrated adj. HRRs of 3.70 (2.24-6.13) for seizures at admission for brain abscess and 1.80 (1.04-3.11) for frontal lobe abscess. By contrast, adj. HRR was 0.42 (0.21-0.86) for occipital lobe abscess. Using the entire registry-based cohort, patients with epilepsy had an adj. MRR of 1.26 (1.01-1.57).
DISCUSSION
Important risk factors of epilepsy were seizures during admission for brain abscess, neurosurgery, alcoholism, frontal lobe abscess, and stroke. Epilepsy was associated with an increased mortality. Antiepileptic treatment may be guided by individual risk profiles, and a specialized follow-up is highlighted by an increased mortality in survivors with epilepsy.
Identifiants
pubmed: 36810235
pii: WNL.0000000000206866
doi: 10.1212/WNL.0000000000206866
pmc: PMC10103119
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1611-e1620Investigateurs
Merete Storgaard
(M)
Christian Østergaard
(C)
Jannik Helweg-Larsen
(J)
Hans Rudolf von Lüttichau
(HR)
Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2023 American Academy of Neurology.
Références
J Neurol Neurosurg Psychiatry. 2010 Aug;81(8):913-7
pubmed: 20682720
Neurology. 2020 Dec 15;95(24):e3213-e3220
pubmed: 32989110
Neuroepidemiology. 1991;10(3):122-31
pubmed: 1922645
Clin Neurol Neurosurg. 2018 Oct;173:46-51
pubmed: 30086427
Acta Neurochir (Wien). 1991;113(3-4):110-7
pubmed: 1799152
J Clin Neurosci. 1997 Jan;4(1):26-8
pubmed: 18638919
Clin Microbiol Infect. 2020 Jan;26(1):95-100
pubmed: 31158518
Acta Neurochir (Wien). 2016 Jul;158(7):1259-67
pubmed: 27113742
N Engl J Med. 2014 Jul 31;371(5):447-56
pubmed: 25075836
Clin Infect Dis. 2020 Aug 14;71(4):1040-1046
pubmed: 31641757
N Engl J Med. 2003 May 1;348(18):1786-95
pubmed: 12724485
Infect Dis (Lond). 2016 Apr;48(4):310-316
pubmed: 26592421
Clin Infect Dis. 2020 Dec 31;71(11):2825-2832
pubmed: 31773138
Brain. 2022 Aug 29;:
pubmed: 36037264
Pract Neurol. 2021 Dec;21(6):481-491
pubmed: 34404748
Acta Neurol Scand. 1983 Jun;67(6):330-7
pubmed: 6613520
J Neurosurg. 1957 May;14(3):249-63
pubmed: 13429394
Lancet. 2019 Feb 16;393(10172):689-701
pubmed: 30686584
Clin Epidemiol. 2018 Oct 12;10:1503-1508
pubmed: 30349397
Brain. 1973 Jun;96(2):259-68
pubmed: 4197584
J Neurol Neurosurg Psychiatry. 2004 Sep;75 Suppl 3:iii16-21
pubmed: 15316040
Epilepsy Res. 2007 Jul;75(2-3):162-70
pubmed: 17624737
Clin Epidemiol. 2015 Nov 17;7:449-90
pubmed: 26604824
Eur J Epidemiol. 2014 Aug;29(8):541-9
pubmed: 24965263